Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin G Leong

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Methods in Molecular Biology (Clifton, N.J.)|July 25, 2020
Modeling Colorectal Cancer Progression Through Orthotopic Implantation of OrganoidsFelipe de Sousa E Melo, Jonathan M Harnoss, Noelyn Kljavin, et al.
Cancer Research|November 24, 2011
Androgen deprivation causes epithelial-mesenchymal transition in the prostate: implications for androgen-deprivation therapyYuting Sun, Bu-Er Wang, Kevin G Leong, et al.
Molecular Cancer Therapeutics|November 18, 2022
Preclinical Characterization of XL092, a Novel Receptor Tyrosine Kinase Inhibitor of MET, VEGFR2, AXL, and MERJeff Hsu, Colin Chong, Jeffrey Serrill, et al.
Nature|May 17, 2011
COP1 is a tumour suppressor that causes degradation of ETS transcription factorsAlberto C Vitari, Kevin G Leong, Kim Newton, et al.
Nature|March 4, 2011
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7Ingrid E Wertz, Saritha Kusam, Cynthia Lam, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Methods in Molecular Biology (Clifton, N.J.)|July 25, 2020
Modeling Colorectal Cancer Progression Through Orthotopic Implantation of OrganoidsFelipe de Sousa E Melo, Jonathan M Harnoss, Noelyn Kljavin, et al.
Cancer Research|November 24, 2011
Androgen deprivation causes epithelial-mesenchymal transition in the prostate: implications for androgen-deprivation therapyYuting Sun, Bu-Er Wang, Kevin G Leong, et al.
Molecular Cancer Therapeutics|November 18, 2022
Preclinical Characterization of XL092, a Novel Receptor Tyrosine Kinase Inhibitor of MET, VEGFR2, AXL, and MERJeff Hsu, Colin Chong, Jeffrey Serrill, et al.
Nature|May 17, 2011
COP1 is a tumour suppressor that causes degradation of ETS transcription factorsAlberto C Vitari, Kevin G Leong, Kim Newton, et al.
Nature|March 4, 2011
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7Ingrid E Wertz, Saritha Kusam, Cynthia Lam, et al.
Pageof 2